In this issue:
Evidence-based consensus guidelines for managing catatonia
LAIs to treat FEP and EP schizophrenia
Evenamide boosts symptom improvement in TRS
Once-daily Ulotaront treatment falls short of endpoints
New neuroimaging approach could improve diagnosis of schizophrenia
Safety and wellbeing of psychiatrists and those in psychiatry training
RANZCP engagement with the pharmaceutical industry
Limited supply of aripiprazole (Abyraz)
NDA for KarXT submitted to FDA
National Mental Health Workforce Strategy 2022–2032
New employment legislation in Australia
Evidence, ethics, and the promise of AI in psychiatry
COVID-19 resources
Conferences, workshops and CPD
Please login below to download this issue (PDF)